Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS44027690HTLV-1ENSG00000171105.14protein_codingINSRYesNo3643P06213
TVIS44033127HTLV-1ENSG00000171105.14protein_codingINSRYesNo3643P06213
TVIS44003490HTLV-1ENSG00000171105.14protein_codingINSRYesNo3643P06213
TVIS44003251HTLV-1ENSG00000171105.14protein_codingINSRYesNo3643P06213
TVIS44047888HTLV-1ENSG00000171105.14protein_codingINSRYesNo3643P06213
TVIS44035075HTLV-1ENSG00000171105.14protein_codingINSRYesNo3643P06213
TVIS44047887HTLV-1ENSG00000171105.14protein_codingINSRYesNo3643P06213
TCGA Plot Options
Drug Information
GeneINSR
DrugBank IDDB11567
Drug NameInsulin peglispro
Target IDBE0000033
UniProt IDP06213
Regulation Type
PubMed IDs27723227; 27512793
CitationsCusi K, Sanyal AJ, Zhang S, Hoogwerf BJ, Chang AM, Jacober SJ, Bue-Valleskey JM, Higdon AN, Bastyr EJ 3rd, Haupt A, Hartman ML: Different effects of basal insulin peglispro and insulin glargine on liver enzymes and liver fat content in patients with type 1 and type 2 diabetes. Diabetes Obes Metab. 2016 Oct;18 Suppl 2:50-58. doi: 10.1111/dom.12751.@@De Meyts P: The Insulin Receptor and Its Signal Transduction Network .
GroupsInvestigational
Direct ClassificationPeptides
SMILES
Pathways
PharmGKB
ChEMBL